Post-Acute Sequelae of SARS-CoV-2 infection
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: This prospective cohort study, conducted from December 2022 to May 2023, enrolled individuals with RT-PCR-confirmed SARS-CoV-2 at baseline, hospitalized at Gansu Provincial Hospital in China.
Exclusion criteria
Exclusion criteria: Exclusion criteria are limited to individuals without available contact details, those who deceased during hospitalization or follow-up, those who declined to participate, and those unreachable for follow-up assessments.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence;EQ-5D-5L; | — |
Secondary
| Measure | Time frame |
|---|---|
| Modified Medical Research Council breathlessness scale;Patient Health Questionnaire-9;Fatigue Severity Scale;Generalized Anxiety Disorder-7;Insomnia Severity Index;EQ-5D-Y;Strength and Difficulties Questionnaire;Pediatric Short Form version 2.0–Fatigue 10a; | — |
Countries
China
Contacts
Gansu Provincial Hospital